Growing clinical research activity in the United States is creating opportunities for innovative RNA therapeutics. Advanced genomic research, specialized clinical centers, and established drug-development infrastructure are supporting the translation of antisense and RNAi technologies into therapeutic applications.
The Antisense and RNAi Therapeutics Market is emerging as a significant segment...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek